News
The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...
FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.
Novavax's COVID-19-influenza vaccines show strong immune response in older adults, paving the way for regulatory approval.
Note that some links may require registration or subscription. An Air India passenger plane bound for London with more than ...
Results showed that the CIC and flu vaccines generated “robust immune responses” across three flu strains (H1N1, H3N2 and B) ...
US biotech Novavax (Nasdaq: NVAX) has reported that its experimental combination COVID-19 and influenza vaccine generated ...
By Ahmed Aboulenein, Julie Steenhuysen and Michael Erman WASHINGTON (Reuters) -U.S. Health Secretary Robert Kennedy Jr. named ...
The strain is more transmissable than previous variants, which has led to increased cases in Ireland. A NEW COVID variant is ...
The Gaithersburg, Md., biotechnology company said Wednesday that results of the initial cohort of vaccines showed both the Covid-19-influenza combination and flu-vaccine candidates induced immune ...
The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned ...
(Reuters) -Shares of global vaccine makers were mixed on Tuesday, as investors assessed U.S. Health Secretary Robert F.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results